[Superior vena cava compression syndrome. Apropos of 69 cases].
Sixty-nine patients with a superior vena cava syndrome were treated by radiotherapy. Forty were also given chemotherapy before or after irradiation. Twenty-nine had bronchial carcinoma, thirteen had other solid tumors, fourteen had lymphosarcoma and thirteen had no histological diagnosis. Subjective improvement was recorded in 86% of cases and the objective response rate was 41%. The response was obtained in a mean period of 4 weeks and its duration was 39 weeks for lymphosarcomas and only 6 weeks for solid tumors. Overall 1 year survival was 18%. Poor results obtained in superior vena cava syndrome incites recommendation of more intensive radiochemotherapeutic management.
D000293:Adolescent; D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009369:Neoplasms / Q000150:complications / Q000628:therapy; D012189:Retrospective Studies; D013577:Syndrome; D014652:Vascular Diseases / Q000209:etiology / Q000628:therapy; D014683:Vena Cava, Superior / Q000473:pathology*
Syndrome de compression de la veine cave supérieure. A propos de soixante-neuf observations.